Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgina V Long

Showing results (1-10 of 574) with videos related to

Pageof 58
Sort By:
Nature Medicine|March 8, 2019
Making a difference to manyGeorgina V Long
The Medical Journal of Australia|February 12, 2015
From dismal prognosis to rising star: melanoma leading the way with new generation cancer therapiesGeorgina V Long
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Diagnosis and treatment of KIT-mutant metastatic melanomaMegan Lyle, Georgina V Long
Current Opinion in Oncology|January 18, 2014
The role of systemic therapies in the management of melanoma brain metastasesMegan Lyle, Georgina V Long
The Lancet. Oncology|August 1, 2014
Systemic treatment for BRAF-mutant melanoma: where do we go next?Alexander M Menzies, Georgina V Long
Therapeutic Advances in Medical Oncology|September 3, 2013
New combinations and immunotherapies for melanoma: latest evidence and clinical utilityAlexander M Menzies, Georgina V Long
JAMA Oncology|August 26, 2016
Recent Developments in Melanoma TherapyAlexander M Menzies, Georgina V Long
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyondAlexander M Menzies, Georgina V Long
The Lancet. Oncology|June 22, 2016
Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trialsPaolo A Ascierto, Georgina V Long
Current Opinion in Oncology|September 16, 2017
Systemic therapy in advanced melanoma: integrating targeted therapy and immunotherapy into clinical practiceInês P Silva, Georgina V Long
Pageof 58

Showing results (1-10 of 574) with videos related to

Sort By:
Pageof 58
Nature Medicine|March 8, 2019
Making a difference to manyGeorgina V Long
The Medical Journal of Australia|February 12, 2015
From dismal prognosis to rising star: melanoma leading the way with new generation cancer therapiesGeorgina V Long
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Diagnosis and treatment of KIT-mutant metastatic melanomaMegan Lyle, Georgina V Long
Current Opinion in Oncology|January 18, 2014
The role of systemic therapies in the management of melanoma brain metastasesMegan Lyle, Georgina V Long
The Lancet. Oncology|August 1, 2014
Systemic treatment for BRAF-mutant melanoma: where do we go next?Alexander M Menzies, Georgina V Long
Therapeutic Advances in Medical Oncology|September 3, 2013
New combinations and immunotherapies for melanoma: latest evidence and clinical utilityAlexander M Menzies, Georgina V Long
JAMA Oncology|August 26, 2016
Recent Developments in Melanoma TherapyAlexander M Menzies, Georgina V Long
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyondAlexander M Menzies, Georgina V Long
The Lancet. Oncology|June 22, 2016
Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trialsPaolo A Ascierto, Georgina V Long
Current Opinion in Oncology|September 16, 2017
Systemic therapy in advanced melanoma: integrating targeted therapy and immunotherapy into clinical practiceInês P Silva, Georgina V Long
Pageof 58